A stereodivergent strategy to both product enantiomers from the same enantiomer of a stereoinducing catalyst: agelastatin

Chemistry - A European Journal

Volumn 15, Issue 28, 2009, Pages 6910-6919

  Trost, Barry M ^a   Dong, Guangbin ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Alkaloids; Antitumor agents; Asymmetric catalysis; Pyrrole; Total synthesis

Indexed keywords

ALKALOIDS; ANTITUMOR AGENTS; ASYMMETRIC CATALYSIS; PYRROLE; TOTAL SYNTHESIS;

CATALYSIS; CATALYSTS; CHIRALITY; DIMETHYL SULFOXIDE; ENANTIOMERS; ENANTIOSELECTIVITY; HYDROCARBONS; IONIC LIQUIDS; NITROGEN COMPOUNDS; PALLADIUM; POTASSIUM COMPOUNDS;

SYNTHESIS (CHEMICAL);

AGELASTATIN A; ALKALOID; COPPER; ORGANOMETALLIC COMPOUND; OXAZOLIDINONE DERIVATIVE; PALLADIUM; PYRROLE DERIVATIVE;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STEREOISOMERISM; SYNTHESIS;

ALKALOIDS; CATALYSIS; COPPER; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; ORGANOMETALLIC COMPOUNDS; OXAZOLIDINONES; PALLADIUM; PYRROLES; STEREOISOMERISM;

EID: 67650502255     PISSN: 09476539     EISSN: 15213765     Source Type: Journal    
DOI: 10.1002/chem.200900794     Document Type: Article

References (62)

1. For a recent review: B. M. Trost, M. L. Crawley, Chem. Rev. 2003, 103, 2921-2944;
2. Also see: B. M. Trost, Chem. Pharm. Bull. 2002, 50, 1-14.
3. a) G. A. Cordell, Ed. The Alkaloids: Chemistry and Biology, Vol. 62, Academic Press, San Diego, 2005, and earlier volumes in the series;
4. b) M. Hesse, Alkaloids: Nature's Curse or Blessing, Wiley-VCH, Weinheim, 2002.
5. a) G. W. Gribble, J. Nat. Prod. 1992, 55, 1353-1395.
6. Also see: b) D.J. Faulkner, Nat. Prod. Rep. 2002, 19, 1-48
7. R. G. S. Berlinck, M. H. Kossuga, Nat. Prod. Rep. 2005, 22, 516-550, and references therein.
8. a) M. D'Ambrosio, A. Guerriero, C. Debitus, O. Ribes, J. Pusset, S. Leroy, F. Pietra, J. Chem. Soc. Chem. Commun. 1993, 1305-1306;
9. b) M. D'Ambrosio, A. Guerriero, G. Chiasera, F. Pietra, Helv. Chim. Acta 1994, 77, 1895-1902
10. M. D'Ambrosio, A. Guerriero, M. Ripamonti, C. Debitus, J. Waikedre, F. Pietra, Helv. Chim. Acta 1996, 79, 727-735.
11. T. W. Hong, D. R. Jimenez, T. F. Molinski, J. Nat. Prod. 1998, 61, 158-161.
12. a) L. Meijer, A. M. Thunnissen, A. W. White, M. Gamier, M. Nikolic, L. H. Tsai, J. Walter, K. E. Cleverley, P. C. Salinas, Y. Z. Wu, J. Biernat, E. M. Mandelkov, S. H. Kim, G. R. Pettit, Chem. Biol. 2000, 7, 51-63;
13. b)G. R. Pettit, S. Ducki, D. L. Herald, D. L. Doubek, J. M. Schmidt, J. C. Chapuis, Oncol. Res. 2005, 15, 11-20;
14. Total synthesis and mechanism of action studies on the antitumour alkaloid, (-)-agelastatin A: K.J. Hale, M. M. Domostoj, M. El-Tanani, F. C. Campbell, C. K. Mason in Strategies and tactics in organic synthesis (Ed.: M. Harmata), Academic Press, London, 2005, pp. 352-394.
15. C. K. Mason, S. McFarlane, P. G. Johnston, P. Crowe, P. J. Erwin, M. M. Domostoj, F. C. Campbell, S. Manaviazar, K. J. Hale, M. ElTanai, Mol. Cancer Ther. 2008, 7, 548-558.
16. K. J. Hale, M. M. Domostoj, D. A. Tocher, E. Irving, F. Scheinmann, Org. Lett. 2003, 5, 2927 -2930.
17. For a review, see: S. M. Weinreb, Nat. Prod. Rep. 2007, 24, 931-948.
18. D. Stien, G. T. Anderson, C. E. Chase, Y.-H. Koh, S. M. Weinreb, J. Am. Chem. Soc. 1999, 121, 9574-9579.
19. a) K. S. Feldman, J. C. Saunders, J. Am. Chem. Soc. 2002, 124, 9060-9061;
20. b)K. S. Feldman, J. C. Saunders, M. L. Wrobleski, J. Org. Chem. 2002, 67, 7096-7109.
21. a) K. J. Hale, M. M. Domostoj, D. A. Tocher, E. Irving, F. Scheinmann, Org. Lett. 2003, 5, 2927-2930;
22. b) M. M. Domostoj, E. Irving, F. Scheinmann, K. J. Hale, Org. Lett. 2004, 6, 2615-2618.
23. F. A. Davis, J. Deng, Org. Lett. 2005, 7, 621-623.
24. P. A. Wehn, PhD Thesis, Stanford University CA (USA), 2005.
25. Y. Ichikawa, T. Yamaoka, K. Nakano, H. Kotsuki, Org. Lett. 2007, 9, 2989-2992.
26. T. Yoshimitsu, T. Ino, T. Tanaka, Org. Lett. 2008, 10, 5457-5460.
27. D. P. Dickson, D. J. Wardrop, Org. Lett. 2009, 11, 1341-1344.
28. For a preliminary report of a portion of our work, see: B. M. Trost, G. Dong, J. Am. Chem. Soc. 2006, 128, 6054-6055.
29. 2, etc.
30. The reason of using (R,R) ligand in this cyclization was initially to examine the possibility of cascading two AAA reactions in one reaction vessel, although here is a mismatched situation.
31. J. U. Jeong, B. Tao, I. Sagasser, H. Henniges, K. B. Sharpless, J. Am. Chem. Soc. 1998, 120, 6844-6845.
32. E. S. Andrade, R. J. Nunes, M. Uieara, Synth. Commun. 2004, 34, 3073-3081.
33. D. A. Evans, M. T. Bilodeau, M. M. Faul, J. Am. Chem. Soc. 1994, 776, 2742-2753.
34. a) M. R. Fructos, T. R. Belderrain, M. C. Nicasio, S. P. Nolan, H. Kaur, M. M. Diaz-Requejo, P. J. Pérez, J. Am. Chem. Soc. 2004, 126, 10846-10847;
35. b) M. R. Fructos, T. R. Belderrain, P. Frément, N. M. Scott, S. P. Nolan, H. Kaur, M. M. Diaz-Requejo, P. J. Pérez, Angew. Chem. 2005, 117, 5418-5422;
36. Angew. Chem. Int. Ed. 2005, 44, 5284-5288;
37. c)R. E. Gawley, S. Narayan, Chem. Commun. 2005, 5109-5111.
38. For a recent improvement and extension of this method to a broad substrate scope, see: Q. Xu, D. H. Appella, Org. Lett. 2008, 10, 1497-1500.
39. T. K. Chakraborty, A. Ghosh, T. V. Raju, Chem. Lett. 2003, 32, 82-83.
40. For a review, see: X. E. Hu, Tetrahedron 2004, 60, 2701-2743.
41. D. B. Dess, J. C. Martin, J. Am. Chem. Soc. 1991, 113, 7277-7287.
42. K. Surendra, N. S. Krishnaveni, M. A. Reddy, Y. V. D. Nageswar, K. R. Rao, J. Org. Chem. 2003, 68, 9119-9121.
43. a) M. A. Khuddus, D. Swern, J Am. Chem. Soc. 1973, 95, 8393-8402;
44. b)T. M. Santosusso, D. Swern, J. Org. Chem. 1975, 40, 2764-2769;
45. T. Cohen, T. Tsuji, J. Org. Chem. 1961, 26, 1681-1681;
46. B. M. Trost, M. J. Fray, Tetrahedron Lett. 1988, 29, 2163-2166.
47. For N-aroylaziridines: a) H. W. Heine, T. Newton, Tetrahedron Lett. 1967, 8, 1859-1860.
48. For N-alkoxycarbonylaziridines: b) S. Fujita, T. Hiyama, H. Nozaki, Tetrahedron Lett. 1969, 10, 1677-1678;
49. S. Fujita, T. Hiyama, H. Nozaki, Tetrahedron 1970, 26, 4347-4352.
50. We thank J. Du Bois and K. Guthikonda for drawing our attention to application of this thermal method for opening trichloroethoxysulfamoylaziridines: K. Guthikonda, P. M. Wehn, B. J. Caliando, J. Du Bois, Tetrahedron 2006, 62, 11331-11342.
51. 3 was not optimized.
52. J. S. Yadav, V. S. Subba Reddy, G. Mahesh Kumar, C. V. S. R. Murthy, Synth. Commun. 2002, 32, 1797-1802, and references therein.
53. J. Cervelló, T. Sastre, Synthesis 1990, 221-222.
54. U. K. Nadir, R. V. Krishna, J. Heterocycl. Chem. 2004, 41, 737-739.
55. P. Carato, S. Yous, D. Sellier, J. H. Poupaert, N. Lebegue, P. Berthelot, Tetrahedron 2004, 60, 10321-10324.
56. a) M. Z. A. Badr, M. M. Aly, A. M. Fahmy, J. Org. Chem. 1981, 46, 4784-4787;
57. b) J.P. Pete, C. Portella, J. Chem. Res. Synop. 1979, 7, 20-21.
58. E. Vedejs, S. Lin, J. Org. Chem. 1994, 59, 1602-1603.
59. Di-anion and in situ silyl protection strategies have been tried but failed.
60. G. T. Anderson, C. E. Chase, Y.-H. Koh, D. Stien, S. M. Weinreb, M. Shang, J. Org. Chem. 1998, 63, 7594-7595.
61. a) K. B. Sharpless, T. Hori, J. Org. Chem. 1976, 41, 176-177;
62. b) R. Bussas, G. Kresze, Liebigs Ann. Chem. 1980, 629-649.